11 Patents
- 0 cites
- US124101332025Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, Compositions and Methods of Use Thereof
Lundbeck La Jolla Research Center, Inc.
0 cites - US120494462024Solid Forms Comprising an Oxime Ether Compound and a Coformer, Compositions and Methods of Use Thereof
NOVARTIS AG
0 cites - US119588052024Solid Forms Comprising an Oxime Ether Compound, Compositions and Methods of Use Thereof
NOVARTIS AG
0 cites - US117013622023Compositions and Methods of Use of Cis-4-[2-{[(3s,4r)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9h-purin-9-yl]-1- Methylcyclohexane-1-carboxamide
Celgene Corporation
0 cites - US116800462023Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl)piperazine-1-carboxylate, Compositions and Methods of Use Thereof
Lundbeck La Jolla Research Center, Inc.
0 cites - US116291242023Solid Forms Comprising an Oxime Ether Compound, Compositions and Methods of Use Thereof
NOVARTIS AG
0 cites - 0 cites